Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL730238 | 0.86 | TSHR (0.43) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 | |
| SCHEMBL20036770 | 0.82 | TSHR (0.34) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 | |
| SCHEMBL17450073 | 0.78 | TP53 (0.37) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 | |
| SCHEMBL14415209 | 0.78 | TSHR (0.36) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 | |
| SCHEMBL732071 | 0.78 | TSHR (0.46) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 | |
| SCHEMBL7876608 | 0.78 | TSHR (0.46) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 | |
| SCHEMBL20853039 | 0.77 | ALDH1A1 (0.40) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 | |
| SCHEMBL13595377 | 0.77 | TSHR (0.33) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 | |
| SCHEMBL9565285 | 0.76 | TSHR (0.41) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 | |
| SCHEMBL472962 | 0.76 | TSHR (0.44) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023238902-A1 | PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, PARTITION WALL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND IMAGE DISPLAY DEVICE | 三菱ケミカル株式会社 | 2023-12-14 | — | — | WO | disclosed |
| US-20100279997-A1 | ANALGESIC THAT BINDS FILAMIN A | PAIN THERAPEUTICS | 2010-11-04 | — | — | US | disclosed |
| WO-2010051374-A1 | ANALGESIC THAT BINDS FILAMIN A | PAIN THERAPEUTICS, INC. (US) | 2010-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100279997-A1 | ANALGESIC THAT BINDS FILAMIN A | FLNA, FLNB, OPRL1 | TSHR 1193/4885SMN1; SMN2 843/4885ALDH1A1 1476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.